Sosei Heptares - Investor and Press Conference on Today's
Tokyo, Japan and Cambridge, UK, 20 July 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), will hold an investor and press conference on today’s...
Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tokyo, Japan and Cambridge, UK, 20 July 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), will hold an investor and press conference on today’s...
Japanese biopharma Sosei Group has bought Swiss-based Idorsia Pharmaceuticals' businesses in Japan and South Korea for about 65 billion yen in its largest acquisition to date. In a...
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd today announced the sale of its operating businesses in the Asia Pacific region , including...
^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating businesses in the Asia Pacific (ex-China) region ("Territory"), including assignment of PIVLAZ (clazosentan) and license rights to daridorexant in ...
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating...